approachtoachildwithjaundice2-131209103904-phpapp02
-
Upload
chris-jara -
Category
Documents
-
view
216 -
download
0
Transcript of approachtoachildwithjaundice2-131209103904-phpapp02
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
1/62
APPROACH TO A CHILD
WITH JAUNDICE
S.BALASANKAR
2009 MBBS
PPRO CH TO CHILD
WITH J UNDICE
S.BALASANKAR
2009 MBBS
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
2/62
JAUNDICE
Jaundice is the visible manifestation of increasedlevel of bilirubin in the body.
It is not a disease rather a symptom of diseases.In adults sclera appears jaundiced when serum bilirubin exceeds 2 mg/dl.
However it is difficult to see sclera in newborndue to difficulty in opening eye. But in new bornit is very easy to see jaundice in skin.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
3/62
BURDEN
Important problem in the 1 st week of life.Almost all neonates (60% Term and 80% Preterm)will have bilirubin > 5 mg/dl in the 1 st week oflife and become visibly jaundiced, vast majority being benignSome of the term babies (8 to 9%) have levelsexceeding 15 mg/dl in 1 st 7 days of life.High bilirubin level is toxic to the developingCNS.( KERNICTERUS; Bilirubin 25 mg/dl )
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
4/62
BILIRUBIN
End product of hemoglobin metabolism that isexcreted in bile.In neonates
-75% : from catabolism of circulating RBCs-25% :*from ineffective erythropoiesis
(bone marrow)*from turnover of heme proteins &free heme( liver).
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
5/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
6/62
Hyperbilirubinemia-Direct( Conjugated)
-Indirect( Un-conjugated)
Conjugated Hyperbilirubinemia is present,* >20% of total bilirubin is conjugated* >2mg/dl is conjugated
If neither criteria is met, hyperbilirubinemia isclassified as Un-conjugated.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
7/62
NEONATAL JAUNDICE
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
8/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
9/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
10/62
b) Prolonged Indirect Jaundice
> Criggler Najjar Syndrome> Breast milk jaundice
> Hypothyroidism> Pyloric stenosis> Ongoing hemolysis, malaria
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
11/62
CLINICAL CLASSIFICATION:
PHYSIOLOGICAL JAUNDICE
PATHOLOGICAL JAUNDICE
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
12/62
PHYSIOLOGICAL JAUNDICE:
In new born babies bilirubinmetabolism is immature which results in theoccurrence of hyperbilirubinemia in the first fewdays of life. Also there is increased bilirubin loadon the hepatic cell due to physiological
polycythemia.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
13/62
Immaturity could be at various steps of bilirubinmetabolism like:
Defective uptake from plasma into liver cell(deficiency of LIGANDIN)Defective conjugation( UDP-glucoronosyltransferase:
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
14/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
15/62
Characteristics:
First appears between hours of ageMaximum intensity seen on 4-5th day in term
and 7th day in preterm neonatesDoes not exceed 15 mg/dlClinically undetectable after 14 days.
No treatment is required but baby should beobserved closely for signs of worsening jaundice.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
16/62
PATHOLOGICAL JAUNDICE
Presence of any of the following signs denotes thatthe jaundice is pathological.
Clinical jaundice detected before 24 hours ofageRise in serum total bilirubin by more than 5
mg/dl/ day (>5mg/dl on first day , 10 mg/dl onsecond day and 12- 13 mg/dl thereafter in term babies)
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
17/62
Serum bilirubin more than 15 mg/dlClinical jaundice persisting beyond 14 days oflifeClay/white colored stool and/or dark urinestaining the nappy yellowDirect bilirubin >2 mg/dl at any time.
Treatment is required in the form of phototherapy or exchange blood transfusion. Oneshould investigate to find the cause of pathological jaundice.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
18/62
It can be
Overproduction Hyperbilirubinemia
Under-secretion Hyperbilirubinemia
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
19/62
Overproduction Hyperbilirubinemia :
Blood group incompatibilitiesMaternal-fetal or feto-fetal transfusions Non Immune Hemolytic anemiasStructurally Abnormal Red cells
Extra-vascular Hemolysis
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
20/62
Blood Group Incompatibilities:
Rh negative mother & Rh positive infant
ABO incompatibilities
Strongly considered if there is jaundice in thefirst 24 hours of life
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
21/62
Non-Immune Hemolytic Anemias:
1. G6PD Deficiency:Deficiency-decreased NADPH- decreased
reduced Glutathione decreased protection ofRBCs from oxidants-hemolysis.
2. Excess of Vitamin K given IM
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
22/62
Structurally Abnormal RBCs:
Spherocytosis
Pyknocytes ( irregular borders)
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
23/62
Under-secretion Hyperbilirubinemia:
Enzymatic Deficiency( Glucoronyl transferase)Hormonal suppression (Breast milk jaundice)
Inhibition of conjugationHepatic cell injury due to InfectionsSubstrate deficiency (hypoglycemia)
Mechanical obstruction (biliary atresia)
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
24/62
Hormonal Suppression:
Pregnandiol present in maternal breast milksuppresses bilirubin conjugation.Breast feeding may be stopped and restarted in a period of 48hours.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
25/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
26/62
Thyroxine Deficiency:
Thyroxine increases the activity of Glucoronyl
transferase which promotes conjugation of bilirubin.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
27/62
Inhibition of Conjugation:
Sulfonamides and Vitamin K results incompetitive conjugation inhibition of bilirubin.
GALACTOSEMIA:Absent or deficient Galactose 1-phosphoate
uridyl transferase which is needed inglucoronidaton of indirect bilirubin.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
28/62
APPROACH
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
29/62
HISTORY
Maternal and Perinatal History:Delivery at period of gestation, Postnatal age inhours.
Maternal illness during pregnancy which alsoincludes diabetes; drug use.Previous history of malaria.Traumatic delivery, delayed cord clamping,oxytocin use.Birth asphyxia, delayed feeding, delay inmeconium passage.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
30/62
Family history of jaundice, liver disease
Previous sibling with jaundice for blood groupincompatibility.Kernicterus: Lethargy, poor feeding, andhypotonia. Some advanced signs are seizures,retrocollis, paralysis of upward gaze and shrillcry.Breast feeding.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
31/62
ON EXAMINATION:
Baby lethargic, poor feeding, temperatureinstability, with apnea: Sepsis
Small for gestation: polycythemia
Cataract, rash: TORCH infections
Extra vascular bleed: Cephalhematoma
Pallor: hemolysis, blood loss
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
32/62
Petechiae: sepsis, TORCH infections.
Hepatosplenomegaly: Rh-isoimmunization,sepsis, TORCH infections.
Dysmorphic features, congenital heart disease(pulmonary stenosis), Intra-hepatic biliary atresia: Alagille syndrome
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
33/62
HOW DO YOU LOOK FORICTERUS?
1. Dermal staining :progresses from head to toeExamined in good day light skin of forehead,
chest, abdomen, thigh, legs, palms, and soles.Blanched with digital pressure and theunderlying color of the skin and subcutaneous
tissue should be noted.
2. Trans-cutaneous bilirubinometer .
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
34/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
35/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
36/62
Clinical Jaundice
> 12 mg/dl and infant < 24 hrold
Fraction of Bilirubin
Indirect Direct
< 12 mg/dl and infant > 24 hrold
Follow bilirubin level
Measure Bilirubin
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
37/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
38/62
Indirect
High(>65%)Polycythemia
Hematocrit
Low/Normal
Reticulocyte countBlood Type
Coombs test Platelets
Evaluate smear
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
39/62
Normal Reticulocyte count
Look for evidence of,*Infections-blood, urine culture
*Enclosed hemorrhage*Congestive cardiac failure
*Hypoxia*Hypothyroidism
*Drugs/toxins
None found
Familial Disorders*Criggler Najjar
*Gilbert
Elevated Reticulocyte Count
Consider:1.Iso-immunization
2.Erythrocyte membrane defect3.Erythrocyte enzyme defect
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
40/62
MANAGEMENT
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
41/62
PHYSIOLOGICAL JAUNDICE
Explain about benign nature of the disease
Encourage to breastfeed frequently & exclusively
Ask Mother to bring baby back if baby looks
deep yellow or palms & soles have yellowstaining.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
42/62
PATHOLOGICAL JAUNDICE
Mainly 2 modalities of Treatment:
PHOTOTHERAPY
EXCHANGE TRANSFUSION
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
43/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
44/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
45/62
Term near term neonates:
The American Academy of Pediatrics (AAP) has
laid down criteria for managing babies withelevated serum bilirubin based on gestationalage and other risk factors( hemolysis ,asphyxia, low albumin level, hypothermia)
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
46/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
47/62
MECHANISMS:
CONFIGURATIONAL ISOMERIZATION
STRUCTURAL ISOMERIZATION
PHOTO OXIDATION
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
48/62
Configurational Isomerization
Z-isomer converted to E-isomerReaction is instantaneous but reversible.
After exposure of 8-12 hrs, this constitutes about25% of the TSB which is non-toxic.Excreted slowly from the body; hence not a
major mechanism for decrease in TSB.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
49/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
50/62
Photo oxidation
Minor reaction
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
51/62
Administering Phototherapy:
Optimum ambient room temperature( 25-28celcius) to prevent hypothermia.Remove all clothes of baby except diaperCover babys eyes with an eye patch(to preventretinal degeneration) ensuring that it does not block the babys nostrils.
Place the baby under the lights in a cot if weightis more than 2kg or in an incubator if baby issmall(
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
52/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
53/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
54/62
Bronze Baby Syndrome
Intense grey-brown discoloration ofthe skin, serum, and urine, especiallyin premature infants; when phototherapy was used to reduce
hyperbilirubinemia. Pre-existinghepatic disease is suspected as acause of the jaundice and may have prevented the biliary excretion of the photo oxidation products of bilirubin; their retention resulted inthe bronze discoloration.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
55/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
56/62
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
57/62
FOLLOWUP
Babies with serum bilirubin>20 mg/dl & thosewho required ET should be kept under follow-upin high-risk clinic for neuro-developmentaloutcome.Hearing assessment should be done at 3monthsof age.
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
58/62
PREVENTION
Ante-natal screening to detect Rh iso-immunization & prompt administration of Anti Dafter first obstetric event.
Ensure adequate breast feeding.Educate parent about danger signs to ensureimmediate checkup.
Follow-up high risk babies( large cephalo-hematoma, family history of jaundice) for 2-3days of discharge.
JAUNDICE IN THE CHILD
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
59/62
JAUNDICE IN THE CHILDADOLESCENT
HISTORY:Age at onset of symptoms. E.g.: Wilsons diseasecommonly manifests in pre-adolescents &
adolescents.Past/present use of any drugsH/o of blood transfusion/ dialysis
Exposure to viral hepatitisAny h/o of chronic illness; hemoglobinopathies.Family h/o of inheritable disorders; Wilsons.
DDs of Un conjugated
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
60/62
DDs of Un-conjugatedHyperbilirubinemia:
Auto-immune hemolytic anemiasDrug induced hemolytic anemias
Erythrocyte membrane defects
Erythrocyte enzyme defects
Hemoglobinopathies
Congestive cardiac failureSepsis
Gilbert syndrome.
DDs of Conjugated
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
61/62
DDs of ConjugatedHyperbilirubinemia:1. Obstructive
Gall stonesPrimary sclerosing cholangitisCholedochal cystTumors
2. InfectionsHepatitis A, B, C, D, E
EBV,CMVVaricella zosterHIVLeptospirosis
-
8/11/2019 approachtoachildwithjaundice2-131209103904-phpapp02
62/62